Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Assessing the severity of tricuspid regurgitation remains a challenging task, and although
echocardiography is the test of choice, significant limitations of the current recommendations …

The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Valvular disease remains a major cause of cardiovascular morbidity and mortality
worldwide. 1 Over the past decade, catheter-based interventions in valvular disease have …

Abstract Background: The SCOUT (Percutaneous Tricuspid Valve Annuloplasty System for
Symptomatic Chronic Functional Tricuspid Regurgitation) trial is a prospective, single-arm …

Background—Functional tricuspid regurgitation (TR) with a structurally normal tricuspid
valve (TV) may occur secondary to chronic atrial fibrillation (AF). However, the clinical and …

731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Current guidelines recommend transthoracic echocardiography to assess patients with
functional tricuspid regurgitation (FTR) because it provides information regarding the …

Aims Quantitative echocardiography parameters are seldom used to grade tricuspid
regurgitation (TR) severity due to relative paucity of validation studies and lack of prognostic …

Significant advances in 3-dimensional echocardiography (3DE) technology have ushered its
use into clinical practice. The recent advent of real-time 3DE using matrix array transthoracic …